Avelumab-induced autoimmune diabetes mellitus

Med Clin (Barc). 2024 Jun 28;162(12):617-618. doi: 10.1016/j.medcli.2023.12.031. Epub 2024 Feb 27.

[Article in English, Spanish]

Authors

Guillermo de Celis Bernat¹, Elena Saba², Elvira Gea Rodríguez³

Affiliations

¹ Unidad de Diabetes, Hospital Nostra Senyora de Meritxell, Escaldes-Engordany, Principado de Andorra. Electronic address: [email protected].
² Unidad de Diabetes, Hospital Nostra Senyora de Meritxell, Escaldes-Engordany, Principado de Andorra.
³ Servicio de Farmacia, Hospital Nostra Senyora de Meritxell, Escaldes-Engordany, Principado de Andorra.

PMID: 38418312
DOI: 10.1016/j.medcli.2023.12.031

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized* / adverse effects
Antibodies, Monoclonal, Humanized* / therapeutic use
Diabetes Mellitus, Type 1* / chemically induced
Female
Humans
Male
Middle Aged

Substances

Antibodies, Monoclonal, Humanized
avelumab